Vivos (RDGL) Interest Coverage Ratio Growth (5y) (2015 - 2025)
Vivos (RDGL) Interest Coverage Ratio Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67.13% |
| Sep 30, 2025 | -17.21% |
| Jun 30, 2025 | -57.80% |
| Mar 31, 2025 | -55.24% |
| Dec 31, 2024 | -15.82% |
| Sep 30, 2024 | -7.72% |
| Jun 30, 2024 | 26.13% |
| Mar 31, 2024 | 18.29% |
| Dec 31, 2023 | -108.82% |
| Sep 30, 2023 | -35.90% |
| Jun 30, 2023 | -219.78% |
| Mar 31, 2023 | -49.34% |
| Dec 31, 2022 | -153.54% |
| Sep 30, 2022 | -37.50% |
| Jun 30, 2022 | -65.69% |
| Mar 31, 2022 | -75.42% |
| Dec 31, 2021 | -137.49% |
| Sep 30, 2021 | 33.40% |
| Jun 30, 2021 | -5.40% |
| Mar 31, 2021 | -31.23% |